Home | My Profile | Contact Us
Research Trends Products  |   order gateway  |   author gateway  |   editor gateway  
ID:
Password:
Register | Forgot Password

Author Resources
 Author Gateway
 Article submission guidelines

Editor Resources
 Editor/Referee Gateway

Agents/Distributors
 Regional Subscription Agents/Distributors
 
Current Topics in Peptide & Protein Research   Volumes    Volume 21 
Abstract
Protein cross-reactivity and blood cancer
Michael J. Dochniak
Pages: 45 - 47
Number of pages: 3
Current Topics in Peptide & Protein Research
Volume 21 

Copyright © 2020 Research Trends. All rights reserved

ABSTRACT
 
Atopy is a medical term for many allergies. When a person has many allergies, a diverse number of immunoglobulin-e antibodies eliminate harmless exogenous-proteins referred to as allergens. The immunoglobulin-e antibodies formed through humoral immunity can bind to endogenous proteins based on structure homology, a cross-react immune response. An over-expression of endogenous proteins is associated with aggressive blood cancer, including leukemia, lymphoma, and myeloma. Cancer immunotherapies seek to stop or inhibit the growth of blood cancer cells. This review proposes cancer immunotherapy involving allergen-specific proteins wherein a hyper-allergenic skin cream induces immunoglobulin-e antibodies that may cross-react with over-expressed proteins associated with acute myeloid leukemia.
View Full Article  


 
search


E-Commerce
Buy this article
Buy this volume
Subscribe to this title
Shopping Cart

Quick Links
Login
Search Products
Browse in Alphabetical Order : Journals
Series/Books
Browse by Subject Classification : Journals
Series/Books

Miscellaneous
Ordering Information Ordering Information
Downloadable forms Downloadable Forms